Vascular permeability alterations induced by arsenic

Human and Experimental Toxicology

Volumn 23, Issue 1, 2004, Pages 1-7

  Chen, Shih Chieh ^a   Tsai, Ming Hsien ^c   Wang, Hsiu Jen ^c   Yu, Hsin Su ^b   Chang, Louis W ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Arsenic; Arsenic toxicity; Vascular injury; Vascular permeability

Indexed keywords

ARSENITE SODIUM; EVANS BLUE; GRAPHITE; INDIAN INK; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; EXPOSURE; EXTRACTION; FURNACE; IN VIVO STUDY; INJECTION SITE; LABELING INDEX; MALE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RADIOASSAY; RAT; SKIN; TIME;

ANIMALS; ARSENITES; CAPILLARY PERMEABILITY; COLORING AGENTS; ENZYME INHIBITORS; EVANS BLUE; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM COMPOUNDS; SPECTROPHOTOMETRY, ATOMIC;

ANIMALIA;

EID: 1442332002     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327104ht407oa     Document Type: Article

References (26)

1. Bates MN, Smith AH, Hopenhayn Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol 1992; 135: 462-76.
2. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JS, Huang CH, Chen CJ. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995; 55: 1296-300.
3. Hutchinson J. Arsenic and cancer. BMJ 1987; 2: 1280-81.
4. Hutchinson J. Diseases of the skin: I. On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Trans Pathoogyl Soc Land 1988; 39: 352-63.
5. Abernathy CO, Calderon RL, Chappell WR. Arsenic: exposure and health effects. London: Kluwer Academic, 1997.
6. Chappell WR, Abernathy CO, Calderon RL. International Conference on Arsenic Exposure and Health Effects staff, Arsenic Exposure and Health Effects. USA: Elsevier, 1999.
7. Chappell WR, Beck BD, Brown KG, Chaney R, Cothern CR, Irgo KJ, North DW, Thornton I, Tsongas TA. Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect 1997; 105: 1060-67.
8. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 1990; 50: 5470-74.
9. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic level in drinking water. Br J Cancer 1992; 66: 888-92.
10. Tseng WP. Effects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977; 19: 109-19.
11. Yu HS, Shen HM, Ko SS, Chiang LC, Chien CH, Lin SM, Tserng BR, Chen CS. Studies on Blackfoot Disease and chronic arsenism in southern Taiwan: with special reference to skin lesions and fluorescent substances. J Dermatol 1984; 11: 361-70.
12. Barchowsky A, Dudek EJ, Treadwell MD, Wetterhahn KE. Arsenic induces oxidant stress and NF-B activation in cultured aortic endothelial cells. Free Radic Biol Med 1996; 21: 783-90.
13. Chang WC, Chen SH, Wu HL, Shi GY, Murota S, Morita I. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology 1991; 69: 101-10.
14. Joris I, Cuenoud HF, Doern GV, Underwood JM, Majno G. Capillary leakage in inflammation: a study by vascular labeling. Am J Pathol 1990; 137: 1353-63.
15. Baluk P, Bolton P, Hirata A, Thurston G, McDonald DM. Endothelial gaps and adherent leukocutes in allergen-induced early and late phase plasma leakage in rat airways. Am J Pathol 1998; 152: 1463-76.
16. Chen SC, Lu TS, Lee LH, Lue SI, Yang RC. Hyperthermic pretreatment decreases microvascular protein leakage and attenuates hypotension in anaphylactic shock in rats. Microvasc Res 2001; 61: 152-59.
17. Udaka K, Takeuchi Y, Movat HZ. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med 1970; 133: 1384-87.
18. Ziada AM, Hudlicka O, Tyler KR, Wright AJ. The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 1984; 18: 724-32.
19. Wang SL, Chiou JM, Chen CJ, Tseng CH, Chou WL, Wu TN, Chang WL. Prevalence of non-insulin dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and non-endemic areas in Taiwan. Environ Health Perspect 2003; 111: 155-60.
20. Deng Y, Xu H, Huang K, Yang X, Xie C, Wu J. Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304. Pharmacol Res 2001; 44: 513-18.
21. Tsai SH, Hsieh MS, Chen L, Liang YC, L JK, Lin SY. Suppression of Fas ligand expression on endothelial cells by arsenite through reactive oxygen species. Toxicol Lett 2001; 123: 11-19.
22. Ayala-Fierro F, Baldwin AL, Wilson LM, Valeski JE, Carter DE. Structural alterations in the rat kidney after acute arsine exposure. Lab Invest 2000; 80: 87-97.
23. Tsou TC, Tsai FY, Wu MC and Chang LW. The protective role of NF-B and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol Appl Pharmacol 2003; 191: 177-87.
24. Yeh JY, Cheng LC, Ou BR, Whanger DP, Chang LW. Differential influences of various arsenic compounds on glutathione redox status and antioxidative enzymes in porcine endothelial cells. Cell Mol Life Sci 2002; 59: 1972-82.
25. Liu F, Jan KY. DNA damage in arsenite and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med 2000; 28: 55-63.
26. Kao YH, Yu CL, Chang LW, Yu HS. Low concentrations of arsenic induces vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vivo. Chem Res Toxicol 2003; 16: 460-68.